These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 25850430)
41. [Cognitive assessment of asymptomatic Huntington's disease carriers]. Gómez-Tortosa E; del Barrio Alba A; Sánchez Pernaute R; Benítez J; Barroso A; García Yébenes J Neurologia; 1997; 12(6):226-31. PubMed ID: 9303588 [TBL] [Abstract][Full Text] [Related]
42. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165 [TBL] [Abstract][Full Text] [Related]
43. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924 [TBL] [Abstract][Full Text] [Related]
44. Intellectual Curiosity and Action Initiation are Subtypes of Apathy Affected in Huntington Disease Gene Expansion Carriers. Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A Cogn Behav Neurol; 2021 Dec; 34(4):295-302. PubMed ID: 34851867 [TBL] [Abstract][Full Text] [Related]
45. Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease. Rodrigues GR; Souza CP; Cetlin RS; de Oliveira DS; Pena-Pereira M; Ujikawa LT; Marques W; Tumas V J Neurol; 2009 Nov; 256(11):1809-15. PubMed ID: 19536583 [TBL] [Abstract][Full Text] [Related]
46. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease. Begeti F; Tan AY; Cummins GA; Collins LM; Guzman NV; Mason SL; Barker RA J Neurol; 2013 Nov; 260(11):2777-85. PubMed ID: 23922130 [TBL] [Abstract][Full Text] [Related]
47. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load. Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766 [TBL] [Abstract][Full Text] [Related]
48. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages. Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902 [TBL] [Abstract][Full Text] [Related]
49. Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Henley SM; Wild EJ; Hobbs NZ; Warren JD; Frost C; Scahill RI; Ridgway GR; MacManus DG; Barker RA; Fox NC; Tabrizi SJ Neuropsychologia; 2008; 46(8):2152-60. PubMed ID: 18407301 [TBL] [Abstract][Full Text] [Related]
50. Variability in cognitive function among persons at high genetic risk of Huntington's disease. Lundervold AJ; Reinvang I Acta Neurol Scand; 1995 Jun; 91(6):462-9. PubMed ID: 7572041 [TBL] [Abstract][Full Text] [Related]
51. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease. Andrews SC; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC Neuropsychology; 2018 Nov; 32(8):958-965. PubMed ID: 30211612 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. Stout JC; Jones R; Labuschagne I; O'Regan AM; Say MJ; Dumas EM; Queller S; Justo D; Santos RD; Coleman A; Hart EP; Dürr A; Leavitt BR; Roos RA; Langbehn DR; Tabrizi SJ; Frost C J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):687-94. PubMed ID: 22566599 [TBL] [Abstract][Full Text] [Related]
53. Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence. Julayanont P; McFarland NR; Heilman KM J Neurol Sci; 2020 Jan; 408():116523. PubMed ID: 31678902 [TBL] [Abstract][Full Text] [Related]
54. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Scahill RI; Hobbs NZ; Say MJ; Bechtel N; Henley SM; Hyare H; Langbehn DR; Jones R; Leavitt BR; Roos RA; Durr A; Johnson H; Lehéricy S; Craufurd D; Kennard C; Hicks SL; Stout JC; Reilmann R; Tabrizi SJ; Hum Brain Mapp; 2013 Mar; 34(3):519-29. PubMed ID: 22102212 [TBL] [Abstract][Full Text] [Related]
55. Screening for cognitive dysfunction in Huntington's disease with the clock drawing test. Terwindt PW; Hubers AA; Giltay EJ; van der Mast RC; van Duijn E Int J Geriatr Psychiatry; 2016 Sep; 31(9):1013-20. PubMed ID: 26766850 [TBL] [Abstract][Full Text] [Related]